Intrinsic Value of S&P & Nasdaq Contact Us

Surrozen, Inc. SRZNW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Surrozen, Inc. (SRZNW) has a negative trailing P/E of -0.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -126.18%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield -126.18% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 45/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
46/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SRZNW

Valuation Multiples
P/E (TTM)-0.8
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio-1.02
P/S Ratio55.16
EV/EBITDA-1.1
Per Share Data
EPS (TTM)$-32.37
Book Value / Share$-25.11
Revenue / Share$0.46
FCF / Share$-4.06
Yields & Fair Value
Earnings Yield-126.18%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -2.4 0.00 2.03 0.00 -
2020 -3.7 0.11 2.55 0.00 -
2021 -4.3 0.10 2.06 0.00 -
2022 -0.6 0.02 0.27 1.62 -
2023 -0.4 -0.01 0.50 0.00 -
2024 -0.7 -0.42 -1.97 3.95 -
2025 -0.7 -0.01 -0.90 48.61 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-61.94 $0.00 $-24.36M -
2020 $-41.01 $0.00 $-32.63M -
2021 $-22.48 $0.00 $-52.51M -
2022 $-11.95 $12.5M $-27.67M -221.4%
2023 $-21.33 $0.00 $-43.04M -
2024 $-21.67 $10.66M $-63.56M -596.6%
2025 $-32.37 $3.48M $-242.03M -6960.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-3.87 $-5.13 – $-2.33 $7.2M $5M – $9M 1
2027 $-3.27 $-4.33 – $-1.97 $1.16M $804.56K – $1.45M 1
2028 $-3.36 $-4.45 – $-2.02 $1.16M $804.56K – $1.45M 1
2029 $-3.57 $-4.73 – $-2.15 $1.16M $804.56K – $1.45M 1
2030 $-3.77 $-5.00 – $-2.27 $6.62M $4.6M – $8.28M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message